Hans-Christian Kolberg Selected Research

Hans-Christian Kolberg Research Topics

Disease

60	Breast Neoplasms (Breast Cancer) 02/2022 - 01/2013
12	Neoplasms (Cancer) 01/2021 - 10/2016
8	Triple Negative Breast Neoplasms 05/2021 - 01/2017
5	Pathologic Complete Response 05/2021 - 01/2013
3	Circulating Neoplastic Cells 01/2021 - 05/2017
3	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2018
2	Cardiotoxicity 06/2021 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 12/2019 - 03/2018
1	Overweight 06/2021
1	Body Weight (Weight, Body) 06/2021
1	Hyperthermia 10/2020
1	Heart Failure 01/2020
1	Stomach Neoplasms (Stomach Cancer) 12/2019
1	Musculoskeletal Pain 10/2019
1	Pain (Aches) 10/2019
1	Arthralgia (Joint Pain) 10/2019
1	Fibrosis (Cirrhosis) 08/2019
1	Brain Neoplasms (Brain Tumor) 12/2018
1	Nausea 03/2018
1	Alopecia (Baldness) 03/2018
1	Vomiting 03/2018
1	Septic Shock (Toxic Shock Syndrome) 01/2018
1	Disease Progression 01/2018
1	Infections 01/2018
1	Neutropenia 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Cystocele 03/2017
1	Prolapse 03/2017

Drug/Important Bio-Agent (IBA)

16	Hormones (Hormone)IBA 05/2021 - 10/2016
6	Trastuzumab (Herceptin)FDA Link 06/2021 - 10/2016
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2022 - 03/2018
5	pertuzumabIBA 06/2021 - 01/2019
5	Biomarkers (Surrogate Marker)IBA 05/2021 - 03/2018
4	AnthracyclinesIBA 01/2021 - 01/2013
3	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2021
3	Immune Checkpoint InhibitorsIBA 05/2021 - 04/2020
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2017
3	taxaneIBA 01/2021 - 01/2013
3	human ERBB2 proteinIBA 01/2020 - 12/2018
3	Letrozole (Femara)FDA LinkGeneric 10/2019 - 01/2017
3	Docetaxel (Taxotere)FDA Link 10/2016 - 01/2013
3	Carboplatin (JM8)FDA LinkGeneric 10/2016 - 01/2013
2	Immunoconjugates (Immunoconjugate)IBA 05/2021 - 04/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2018
2	Ado-Trastuzumab EmtansineIBA 10/2020 - 10/2019
2	Biosimilar PharmaceuticalsIBA 01/2020 - 12/2019
2	Aromatase InhibitorsIBA 10/2019 - 01/2017
1	giredestrantIBA 02/2022
1	talazoparibIBA 02/2022
1	neratinibIBA 06/2021
1	Capecitabine (Xeloda)FDA Link 06/2021
1	Cyclin-Dependent Kinase 4IBA 05/2021
1	AlpelisibIBA 04/2021
1	sacituzumab govitecanIBA 04/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	histidine-rich proteinsIBA 11/2020
1	seribantumabIBA 11/2020
1	atezolizumabIBA 12/2019
1	Monoclonal AntibodiesIBA 12/2019
1	Biological ProductsIBA 10/2019
1	Estrogen ReceptorsIBA 12/2018
1	Aurora Kinase AIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	TensinsIBA 05/2017
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 05/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2017
1	polyvinylidene fluoride (PVDF)IBA 03/2017
1	Epidermal Growth Factor (EGF)IBA 10/2016

Therapy/Procedure

35	Therapeutics 01/2022 - 12/2015
15	Neoadjuvant Therapy 02/2022 - 07/2015
13	Drug Therapy (Chemotherapy) 05/2021 - 01/2013
5	Radiotherapy 10/2020 - 01/2017
5	Segmental Mastectomy (Lumpectomy) 10/2019 - 01/2017
2	Immunotherapy 12/2019 - 10/2019
2	Precision Medicine 11/2018 - 11/2018
1	Combination Drug Therapy (Combination Chemotherapy) 12/2019
1	Lymph Node Excision (Lymph Node Dissection) 01/2018
1	Complementary Therapies (Alternative Medicine) 01/2017
1	Contraindications 01/2017
1	Adjuvant Chemotherapy 10/2016